Literature DB >> 2184724

Critical appraisal of therapeutic endoscopy in biliary tract diseases.

P B Cotton1.   

Abstract

Endoscopic treatment (by sphincterotomy) is now the preferred method for patients with retained or recurrent bile duct stones after surgery. It is also applicable to many acutely ill or high-risk patients who have not undergone cholecystectomy. Endoscopic stenting is preferable to the percutaneous transhepatic method for palliation of malignant biliary obstruction in patients unfit or unsuitable for surgery. Balloon dilatation and stenting can be used for management of postoperative bile duct trauma and biliary fistulae, and in patients with dominant strictures in sclerosing cholangitis. Papillary stenosis and sphincter of Oddi dysfunction can be treated by sphincterotomy after careful patient selection. Endoscopy is a new and simpler form of surgery. A team approach including endoscopists, surgeons, and radiologists is essential for appropriate patient care and for objective evaluation of new methods.

Entities:  

Mesh:

Year:  1990        PMID: 2184724     DOI: 10.1146/annurev.me.41.020190.001235

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  4 in total

Review 1.  Endoscopic stenting for palliation of malignant biliary obstruction. A review of progress in the last 15 years.

Authors:  J J Sung; S C Chung
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

Review 2.  Bacterial biofilm and clogging of biliary stents.

Authors:  J J Sung
Journal:  J Ind Microbiol       Date:  1995-09

3.  ERCP in the management of patients having laparoscopic cholecystectomy: re-appraising current indications.

Authors:  A Quershi; A Browne; A L Leahy; G Courtney; H Osborne; P J Broe; D Bouchier-Hayes
Journal:  Ir J Med Sci       Date:  1993-12       Impact factor: 1.568

4.  Cutting balloon treatment of anastomotic biliary stenosis after liver transplantation: Report of two cases.

Authors:  Fan Ding; Hui Tang; Chi Xu; Zai-Bo Jiang; Shu-Hong Yi; Hua Li; Nan Jiang; Wen-Jie Chen; Qing Yang; Yang Yang; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.